Skip to main content

MedAvail Ranked in the Top 500 Fastest-Growing Companies in North America

PHOENIX, Nov. 17, 2022 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced that it ranked for the first time on the Deloitte Technology Fast 500™, an award aimed at recognizing innovative technology companies that redefine the cutting edge.

The award recognized MedAvail’s mission to transform the retail pharmacy industry by offering turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform – its MedCenter. Technology Fast 500 awardees are selected based on the percentage revenue growth from 2018 to 2021. MedAvail reported total revenue of $22.1 million in 2021, representing 374% growth since 2018.

“We are incredibly honored to have been distinguished among the top 500 fastest-growing innovative technology companies by an award that demonstrates our strong growth over the last few years. We are also excited to see our momentum continue in 2022, as we expand our retail pharmacy footprint and broaden our technology pipeline,” said Mark Doerr, chief executive officer of MedAvail. “We see a significant opportunity ahead for MedAvail as our team continues with strong execution across strategic initiatives and focus on improving patient medication access and adherence with our differentiated technology solution.”

About the 2022 Deloitte Technology Fast 500™

Now in its 28th year, the Deloitte Technology Fast 500 honors the most innovative, fastest-growing public and private companies all over North America. The awards program was created to recognize the passion and dedication it takes to be a disruptor across different industries, including the technology and life sciences sectors. The rankings are compiled based on submitted applications and public company database research, with winners selected based on their percentage fiscal-year revenue growth over a three-year period.

About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

Contacts:

Investor Relations
Ji-Yon Yi
Gilmartin Group
ir@medavail.com
SOURCE MedAvail Holdings, Inc.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.